Ascletis Pharma Inc.
1672
Rangering i aksjer
#10492
Ascletis Pharma Inc., a biotechnology company, engages in the research and... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
Aksjekurs
$0.74836845
Sist synkronisert: 2026-10-16
Markedsverdi
$785.53M
Endring (1 dag)
1.12%
Endring (1 år)
-38.66%
Land
CN
Handel Ascletis Pharma Inc. (1672)
Kategori
Healthcare
Markedsverdi av Ascletis Pharma Inc.(1672)
Markedsverdi: $785.53M
Per October 2026 har Ascletis Pharma Inc. en markedsverdi på $785.53M. Dette gjør Ascletis Pharma Inc. til det 10492nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Ascletis Pharma Inc. fra 2019 til 2026
1672 sammenlignet med topp 5 mest populære stocks
